Blue Chip Partners LLC Lowers Position in The Procter & Gamble Company (NYSE:PG)

Blue Chip Partners LLC reduced its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 0.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,840 shares of the company’s stock after selling 139 shares during the period. Blue Chip Partners LLC’s holdings in Procter & Gamble were worth $3,437,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Alera Investment Advisors LLC raised its stake in Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares in the last quarter. Fiduciary Alliance LLC increased its holdings in shares of Procter & Gamble by 2.8% in the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after acquiring an additional 61 shares during the last quarter. LCM Capital Management Inc raised its position in shares of Procter & Gamble by 1.1% during the 1st quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock valued at $925,000 after acquiring an additional 63 shares in the last quarter. Home Federal Bank of Tennessee lifted its stake in Procter & Gamble by 0.3% during the second quarter. Home Federal Bank of Tennessee now owns 23,318 shares of the company’s stock worth $3,846,000 after purchasing an additional 63 shares during the last quarter. Finally, Prentice Wealth Management LLC boosted its holdings in Procter & Gamble by 1.6% in the second quarter. Prentice Wealth Management LLC now owns 4,059 shares of the company’s stock worth $669,000 after purchasing an additional 64 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $170.03 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $171.89. The business’s 50 day moving average price is $167.37 and its two-hundred day moving average price is $163.89. The company has a market cap of $401.29 billion, a PE ratio of 27.78, a price-to-earnings-growth ratio of 3.64 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business’s revenue was down .1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.37 earnings per share. On average, analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s dividend payout ratio is 65.69%.

Insiders Place Their Bets

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Susan Street Whaley sold 450 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the transaction, the insider now directly owns 13,072 shares in the company, valued at $2,212,043.84. The disclosure for this sale can be found here. Insiders have sold a total of 375,553 shares of company stock worth $63,829,141 in the last quarter. Corporate insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Citigroup upped their target price on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. TD Cowen started coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 target price for the company. Deutsche Bank Aktiengesellschaft lifted their price target on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Stifel Nicolaus boosted their price objective on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research report on Monday, July 22nd. Finally, DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target for the company in a research report on Thursday. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $175.79.

Check Out Our Latest Stock Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.